We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a m... ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever. Show more
ProtoKinetix Upgrades to OTCQB PR Newswire ST. MARYS, W.Va., June 8, 2015 ST. MARYS, W.Va., June 8, 2015 /PRNewswire/ -- ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix...
ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) (“ProtoKinetix” or the “Company”) is pleased to announce that it has completed the acquisition of a portion of certain patents...
ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) (“ProtoKinetix” or the “Company”) is pleased to announce that it has completed the acquisition of certain patents and all...
ProtoKinetix, Incorporated (OTC: PKTX) (the “Company” or “Protokinetix”) (www.protokinetix.com) is pleased to announce that it has entered into consulting agreements with Clarence E...
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "Protokinetix") (www.protokinetix.com) is pleased to announce that it has completed a private placement (the “Offering”) for gross...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00248 | 24.8 | 0.01 | 0.0135 | 0.009675 | 90698 | 0.01022641 | CS |
4 | 0.00148 | 13.4545454545 | 0.011 | 0.0142 | 0.0082 | 73181 | 0.01167256 | CS |
12 | -0.00142 | -10.2158273381 | 0.0139 | 0.0144 | 0.0082 | 54817 | 0.01228164 | CS |
26 | -0.00252 | -16.8 | 0.015 | 0.0197 | 0.008 | 97440 | 0.01315402 | CS |
52 | -0.01052 | -45.7391304348 | 0.023 | 0.0289 | 0.008 | 110697 | 0.01566565 | CS |
156 | -0.08752 | -87.52 | 0.1 | 0.1376 | 0.008 | 89939 | 0.03286768 | CS |
260 | -0.10752 | -89.6 | 0.12 | 0.27 | 0.008 | 86245 | 0.07678446 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions